OLD Category: Oncology

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer

• Kulbe H et al.,

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma

• Wirsching HG et al.,

A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening

• Stackhouse CT et al.,

Efficient tumor clearance and diversified immunity through neoepitope vaccines and combinatorial immunotherapy

• Lee KL et al.,

Optimizing oncolytic virotherapy in cancer treatment

• Harrington K et al.,

A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer

• Yang PS et al.,

Development of mouse models of angiosarcoma driven by p53

• Salter dm et al.,

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

• Chen X et al.,

A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort

• Tien AC et al.,

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

• Sin-Chan P et al.,

Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing

• Pararajalingam P et al.,

A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma

• Kim SS et al.,